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SUMMARY. The prolonged residence of drug formulation in the nasal cavity is of utmost importance for
intranasal drug delivery. The objective of the present investigation was to develop a mucoadhesive in situ
gel with reduced nasal mucocilliary clearance in order to improve the bioavailability of the antiemetic
drug, metoclopramide hydrochloride. The in situ gelation upon contact with nasal mucosa was conferred
via the use of the thermogelling Pluronic flake 127 (18%). Mucoadhesion was modulated via the use of hy-
droxy propyl methyl cellulose (HPMC), sodium carboxy methyl cellulose (Na CMC) and sodium alginate
(Na-alginate) whereas drug release was modified by varying concentrations of polyethylene glycol 6000
(PEG 6000). The results revealed that the different mucoadhesives increased the gel viscosity but reduced
its sol gel transition temperatures. The increase in viscosity was highest in formulations with Na-alginate
and lowest in formulations with HPMC. PEG 6000 significantly decreased mucoadhesive strength of for-
mula containing 0.3% HPMC (776.6 ± 19.55 to 713.6 ± 5.03), 0.2% Na CMC (656 ± 11.13 to 575 ± 9.07)
and 0.2% Na-alginate (659 ± 11.13 to 618.3 ± 9.45) whereas the gelation temperature increased by 3 to 4
°C. 100% of drug diffusion was found at four hours for formulation F5, F9, and F12. Formulation F5
showed maximum permeability (0.00949 ± 0.00021 mg.cm/min) than other formulation containing
PEG6000. This study concluded the potential use of mucoadhesive in situ nasal gel in terms of ease of ad-
ministration, accuracy of dosing, prolonged nasal residence and improved nasal bioavailability. 
